Yes, Evolus's flagship aesthetic neurotoxin, Jeuveau (prabotulinumtoxinA-xvfs), is fully FDA-approved for commercial use in the United States to temporarily improve the appearance of moderate to severe frown lines between the eyebrows in adult patients, backed by rigorous clinical trials and regulatory safety compliance.